Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vapendavir in adults with moderate to severe asthma and symptomatic human rhinovirus infection
2014-001785-95Phase 2Completed
- Sponsor
- Aviragen Therapeutics
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in rhinoviral infection and asthma comparing Vapendavir with Placebo (2 arms). Primary endpoint: Change from baseline to Study Day 14 in ACQ-6 total score. Started Dec 2014; status: completed.
02
Drugs
Vapendavir
03
Conditions
rhinoviral infectionasthma
Beyond the preview
Go deeper on 2014-001785-95.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001785-95.